Search Results

Containing any of the words

Only of the type

Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Biscor film-coated tablets (10 mg bisoprolol fumarate) Produced by Pharma International / Jordan versus Concor® film-coated tablets (10 mg bisoprolol fumarate) Produced by Merck / Germany, in healthy subjects under fasting condition. Drug Clinical Trial

SFDA Withdrawal a Batch for the Profinal Susp 100mg-5ml (110ml) which Produced by the manufacturer JULPHAR duo to Quality Defect Warnings

A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART) Drug Clinical Trial

A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART) Drug Clinical Trial

A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients Drug Clinical Trial

A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients Drug Clinical Trial

A prospective, observational, non-randomized, European, multi-center registry, collecting REal-life information for the utilization of instantaneous wave-free ratio™ (iFR®) in Assessing coronary stenosis relevance in the Multi-vesseL disease patients population (REAL). Clinical Trial

SFDA Showcases Smart Technologies and Interactive Experiences at LEAP 2025 News

SFDA CEO Inaugurates the 3rd Meeting of the OIC Heads of National Medicines Regulatory Authorities News

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis Warnings